Elizabeth Jeffries Rossin, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eye Injuries | 3 | 2023 | 227 | 1.880 |
Why?
|
Vitrectomy | 4 | 2022 | 392 | 1.270 |
Why?
|
Visual Acuity | 5 | 2024 | 2714 | 1.260 |
Why?
|
Central Serous Chorioretinopathy | 2 | 2024 | 32 | 1.120 |
Why?
|
Intravitreal Injections | 2 | 2024 | 401 | 1.000 |
Why?
|
Receptor, TIE-2 | 1 | 2024 | 182 | 0.890 |
Why?
|
Complement Factor H | 1 | 2023 | 110 | 0.850 |
Why?
|
Eye Injuries, Penetrating | 1 | 2023 | 121 | 0.770 |
Why?
|
Fluorescein Angiography | 2 | 2024 | 1086 | 0.740 |
Why?
|
Cataract Extraction | 2 | 2022 | 465 | 0.720 |
Why?
|
Ophthalmic Artery | 1 | 2021 | 58 | 0.720 |
Why?
|
Retinal Artery | 1 | 2021 | 109 | 0.700 |
Why?
|
Scleral Buckling | 1 | 2020 | 95 | 0.690 |
Why?
|
Retinal Hemorrhage | 1 | 2020 | 98 | 0.680 |
Why?
|
Orbital Fractures | 1 | 2021 | 109 | 0.670 |
Why?
|
Intracranial Embolism | 1 | 2021 | 189 | 0.660 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2022 | 342 | 0.650 |
Why?
|
Endophthalmitis | 1 | 2022 | 262 | 0.640 |
Why?
|
Eye Infections, Bacterial | 1 | 2022 | 239 | 0.640 |
Why?
|
Cataract | 2 | 2022 | 837 | 0.630 |
Why?
|
Lens Subluxation | 1 | 2018 | 23 | 0.620 |
Why?
|
Embolism | 1 | 2021 | 401 | 0.570 |
Why?
|
Marfan Syndrome | 1 | 2018 | 237 | 0.530 |
Why?
|
Lens, Crystalline | 1 | 2018 | 387 | 0.530 |
Why?
|
Retinal Detachment | 1 | 2020 | 429 | 0.530 |
Why?
|
Ophthalmology | 2 | 2022 | 560 | 0.470 |
Why?
|
Self-Injurious Behavior | 1 | 2020 | 568 | 0.460 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2038 | 0.420 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2020 | 1039 | 0.410 |
Why?
|
Vitreoretinopathy, Proliferative | 2 | 2024 | 75 | 0.400 |
Why?
|
Tomography, Optical Coherence | 1 | 2024 | 2957 | 0.370 |
Why?
|
Infant, Premature | 1 | 2020 | 2124 | 0.360 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2006 | 0.360 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 2 | 2024 | 355 | 0.350 |
Why?
|
Retina | 1 | 2020 | 2661 | 0.330 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2533 | 0.330 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2021 | 827 | 0.270 |
Why?
|
Algorithms | 2 | 2021 | 14154 | 0.260 |
Why?
|
Genome-Wide Association Study | 14 | 2023 | 12778 | 0.240 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2024 | 3520 | 0.230 |
Why?
|
Genetic Loci | 6 | 2023 | 2630 | 0.230 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2024 | 664 | 0.210 |
Why?
|
Medicare Part B | 1 | 2024 | 117 | 0.210 |
Why?
|
Genome | 1 | 2011 | 1747 | 0.200 |
Why?
|
Propionibacterium acnes | 1 | 2022 | 59 | 0.200 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2022 | 91 | 0.200 |
Why?
|
Helminths | 1 | 2022 | 39 | 0.200 |
Why?
|
Antibodies, Bispecific | 1 | 2024 | 204 | 0.190 |
Why?
|
Crohn Disease | 2 | 2011 | 2293 | 0.180 |
Why?
|
Silicone Oils | 1 | 2020 | 22 | 0.180 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2021 | 4646 | 0.180 |
Why?
|
Endotamponade | 1 | 2020 | 37 | 0.180 |
Why?
|
Immunodominant Epitopes | 1 | 2021 | 244 | 0.180 |
Why?
|
Retrospective Studies | 7 | 2024 | 81801 | 0.170 |
Why?
|
Arthritis, Rheumatoid | 2 | 2013 | 3777 | 0.160 |
Why?
|
Trauma Severity Indices | 1 | 2020 | 479 | 0.160 |
Why?
|
Carotid Artery, Internal | 1 | 2021 | 445 | 0.150 |
Why?
|
Recombinant Fusion Proteins | 2 | 2024 | 3731 | 0.150 |
Why?
|
Anterior Chamber | 1 | 2018 | 194 | 0.150 |
Why?
|
Humans | 42 | 2024 | 768393 | 0.140 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2021 | 1362 | 0.140 |
Why?
|
Triage | 2 | 2022 | 994 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2018 | 12241 | 0.140 |
Why?
|
Retinopathy of Prematurity | 1 | 2021 | 449 | 0.140 |
Why?
|
Angiogenesis Inhibitors | 2 | 2024 | 2060 | 0.130 |
Why?
|
Postoperative Period | 1 | 2020 | 1830 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 755 | 0.130 |
Why?
|
Macular Degeneration | 1 | 2023 | 1016 | 0.130 |
Why?
|
Retinal Diseases | 1 | 2021 | 710 | 0.120 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9261 | 0.120 |
Why?
|
Magnetic Resonance Angiography | 1 | 2021 | 1434 | 0.110 |
Why?
|
RNA, Messenger | 2 | 2024 | 12805 | 0.110 |
Why?
|
Cardiomegaly | 1 | 2016 | 591 | 0.110 |
Why?
|
Brain | 1 | 2020 | 27454 | 0.110 |
Why?
|
Long QT Syndrome | 2 | 2014 | 472 | 0.100 |
Why?
|
Aged | 10 | 2024 | 171562 | 0.100 |
Why?
|
AIDS Vaccines | 1 | 2019 | 900 | 0.100 |
Why?
|
Minisatellite Repeats | 1 | 2013 | 164 | 0.100 |
Why?
|
Male | 15 | 2024 | 364902 | 0.100 |
Why?
|
Ischemia | 1 | 2021 | 1900 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 8 | 2018 | 18048 | 0.100 |
Why?
|
Prognosis | 3 | 2023 | 30022 | 0.100 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2013 | 166 | 0.100 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15939 | 0.100 |
Why?
|
Gestational Age | 1 | 2020 | 3615 | 0.090 |
Why?
|
Antigen-Antibody Reactions | 1 | 2011 | 342 | 0.090 |
Why?
|
Flow Cytometry | 3 | 2011 | 5900 | 0.090 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 605 | 0.090 |
Why?
|
Infant, Newborn | 3 | 2021 | 26411 | 0.090 |
Why?
|
Mutation | 5 | 2023 | 30228 | 0.090 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11918 | 0.090 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2019 | 2202 | 0.090 |
Why?
|
Cells | 1 | 2011 | 166 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 10 | 2018 | 16028 | 0.080 |
Why?
|
Middle Aged | 8 | 2024 | 223491 | 0.080 |
Why?
|
Calcium Signaling | 1 | 2014 | 739 | 0.080 |
Why?
|
Peptides | 1 | 2021 | 4353 | 0.080 |
Why?
|
Phenotype | 4 | 2023 | 16721 | 0.080 |
Why?
|
Case-Control Studies | 5 | 2021 | 22296 | 0.080 |
Why?
|
Critical Care | 1 | 2022 | 2716 | 0.080 |
Why?
|
Female | 15 | 2024 | 397089 | 0.080 |
Why?
|
Sheep | 1 | 2011 | 1451 | 0.080 |
Why?
|
Mucin-1 | 1 | 2013 | 538 | 0.080 |
Why?
|
Alleles | 5 | 2021 | 6892 | 0.070 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2013 | 1339 | 0.070 |
Why?
|
Boston | 1 | 2021 | 9371 | 0.070 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18362 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2022 | 5367 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2021 | 3008 | 0.070 |
Why?
|
Cluster Analysis | 2 | 2011 | 2728 | 0.070 |
Why?
|
Adult | 8 | 2024 | 223640 | 0.070 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2012 | 600 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2016 | 9614 | 0.070 |
Why?
|
Arrhythmias, Cardiac | 2 | 2014 | 2258 | 0.070 |
Why?
|
Rabbits | 2 | 2024 | 4781 | 0.070 |
Why?
|
Risk Factors | 4 | 2022 | 74962 | 0.070 |
Why?
|
Exons | 1 | 2012 | 2392 | 0.060 |
Why?
|
Young Adult | 3 | 2022 | 60049 | 0.060 |
Why?
|
Autistic Disorder | 2 | 2012 | 1240 | 0.060 |
Why?
|
Receptors, Interleukin-6 | 1 | 2007 | 224 | 0.060 |
Why?
|
Chromosome Aberrations | 1 | 2012 | 1780 | 0.060 |
Why?
|
Software | 2 | 2011 | 4453 | 0.060 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2007 | 640 | 0.060 |
Why?
|
Transcription Factors | 2 | 2016 | 12166 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3107 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15455 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7463 | 0.050 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2008 | 558 | 0.050 |
Why?
|
Adolescent | 2 | 2021 | 89184 | 0.050 |
Why?
|
DNA | 1 | 2016 | 7211 | 0.050 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 1753 | 0.050 |
Why?
|
Eye Pain | 1 | 2022 | 46 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2022 | 59686 | 0.050 |
Why?
|
Gene Deletion | 1 | 2009 | 2673 | 0.050 |
Why?
|
HIV-1 | 1 | 2019 | 6963 | 0.050 |
Why?
|
Heart Rate | 1 | 2013 | 4218 | 0.050 |
Why?
|
Protein Denaturation | 1 | 2021 | 242 | 0.050 |
Why?
|
Quantitative Trait Loci | 3 | 2013 | 2127 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2022 | 412 | 0.040 |
Why?
|
Migraine Disorders | 1 | 2013 | 1713 | 0.040 |
Why?
|
Emulsions | 1 | 2020 | 152 | 0.040 |
Why?
|
Proteomics | 1 | 2014 | 3906 | 0.040 |
Why?
|
Fundus Oculi | 1 | 2022 | 560 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2008 | 1813 | 0.040 |
Why?
|
Italy | 1 | 2022 | 854 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2022 | 15881 | 0.040 |
Why?
|
Protein Stability | 1 | 2021 | 580 | 0.040 |
Why?
|
Risk Assessment | 1 | 2021 | 24318 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2011 | 2257 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39407 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 40272 | 0.040 |
Why?
|
Animals | 8 | 2024 | 169337 | 0.040 |
Why?
|
Surface Properties | 1 | 2021 | 1167 | 0.040 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 215 | 0.040 |
Why?
|
Models, Biological | 2 | 2011 | 9493 | 0.040 |
Why?
|
HLA-B Antigens | 1 | 2019 | 328 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 42650 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2007 | 3230 | 0.030 |
Why?
|
Genomics | 2 | 2009 | 5916 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2019 | 1163 | 0.030 |
Why?
|
HLA Antigens | 1 | 2021 | 1337 | 0.030 |
Why?
|
Drug Costs | 1 | 2024 | 1196 | 0.030 |
Why?
|
Genotype | 3 | 2018 | 13042 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2022 | 1882 | 0.030 |
Why?
|
Protein Binding | 2 | 2018 | 9343 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 17575 | 0.030 |
Why?
|
Vision Disorders | 1 | 2022 | 1093 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2016 | 399 | 0.030 |
Why?
|
Schizophrenia | 2 | 2012 | 6987 | 0.030 |
Why?
|
Child | 2 | 2020 | 80891 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 65379 | 0.030 |
Why?
|
Sex Factors | 2 | 2022 | 10654 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2009 | 3247 | 0.030 |
Why?
|
Mice | 3 | 2024 | 82017 | 0.030 |
Why?
|
Gene Frequency | 2 | 2013 | 3617 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2016 | 4775 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36849 | 0.030 |
Why?
|
Nanoparticles | 1 | 2024 | 1987 | 0.030 |
Why?
|
Comorbidity | 2 | 2022 | 10588 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4291 | 0.020 |
Why?
|
Chromosome Breakage | 1 | 2012 | 159 | 0.020 |
Why?
|
Cytosine | 1 | 2013 | 213 | 0.020 |
Why?
|
Pakistan | 1 | 2012 | 298 | 0.020 |
Why?
|
Virus Replication | 1 | 2019 | 2458 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2012 | 509 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3587 | 0.020 |
Why?
|
Xenopus laevis | 1 | 2014 | 966 | 0.020 |
Why?
|
Antigens, CD19 | 1 | 2013 | 437 | 0.020 |
Why?
|
Genome, Human | 2 | 2016 | 4450 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 2009 | 4622 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9682 | 0.020 |
Why?
|
Diabetic Retinopathy | 1 | 2018 | 1299 | 0.020 |
Why?
|
Proteome | 1 | 2019 | 1881 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2024 | 10478 | 0.020 |
Why?
|
Nervous System | 1 | 2012 | 547 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 798 | 0.020 |
Why?
|
Genes | 1 | 2012 | 1824 | 0.020 |
Why?
|
Sequence Analysis | 1 | 2009 | 240 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3906 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2013 | 742 | 0.020 |
Why?
|
Heart Conduction System | 1 | 2013 | 1009 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2013 | 2342 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2012 | 1998 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 937 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2012 | 1390 | 0.020 |
Why?
|
Binding Sites | 1 | 2016 | 6017 | 0.020 |
Why?
|
Family Health | 1 | 2012 | 1255 | 0.020 |
Why?
|
Logistic Models | 1 | 2022 | 13323 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2013 | 1428 | 0.020 |
Why?
|
Haplotypes | 1 | 2013 | 2724 | 0.020 |
Why?
|
Lod Score | 1 | 2007 | 600 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 2014 | 1568 | 0.020 |
Why?
|
Cerebellum | 1 | 2013 | 1514 | 0.020 |
Why?
|
Demyelinating Diseases | 1 | 2008 | 358 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12422 | 0.020 |
Why?
|
NF-kappa B | 1 | 2013 | 2489 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2009 | 1364 | 0.010 |
Why?
|
Blood Glucose | 1 | 2018 | 6430 | 0.010 |
Why?
|
Multifactorial Inheritance | 1 | 2012 | 1421 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2008 | 1866 | 0.010 |
Why?
|
DNA Copy Number Variations | 1 | 2012 | 2046 | 0.010 |
Why?
|
Remission Induction | 1 | 2009 | 2407 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2009 | 2363 | 0.010 |
Why?
|
Zebrafish | 1 | 2014 | 3037 | 0.010 |
Why?
|
Computer Simulation | 1 | 2016 | 6277 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2009 | 1374 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2009 | 1748 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2014 | 3838 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2009 | 1855 | 0.010 |
Why?
|
Models, Genetic | 1 | 2012 | 3442 | 0.010 |
Why?
|
Prospective Studies | 2 | 2022 | 54920 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1623 | 0.010 |
Why?
|
Myocardium | 1 | 2014 | 4788 | 0.010 |
Why?
|
Computational Biology | 1 | 2013 | 3543 | 0.010 |
Why?
|
Electrocardiography | 1 | 2014 | 6409 | 0.010 |
Why?
|
Genetic Variation | 1 | 2016 | 6606 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2013 | 3666 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4142 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4785 | 0.010 |
Why?
|
Cell Membrane | 1 | 2009 | 3663 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36510 | 0.010 |
Why?
|
Signal Transduction | 2 | 2013 | 23631 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8326 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2009 | 3078 | 0.010 |
Why?
|
United States | 1 | 2024 | 73150 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2009 | 3112 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15597 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10267 | 0.010 |
Why?
|